Mobile App

Google Play Apple Store
Independent Coverage from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting*
Certified AMA Activity - Clinical Clip
Immunotherapy approaches have revolutionized the treatment of melanoma and ongoing studies are focused on improving outcomes and reducing toxicities with existing and novel therapies. To ensure updated ongoing care for patients, clinicians need to stay abreast with recent clinical trial evidence from different settings of melanoma treatment.

This educational Clinical Clip will highlight important advances in immunotherapy approaches for melanoma based on data presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting.
Review the video to claim AMA credit after completion of the brief Post-Test/Evaluations.
Hussein Tawbi, MD, PhD
Hussein Tawbi, MD, PhD
Professor, UT MD Anderson Cancer Center


 


*This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings of the 2021 American Society of Clinical Oncology Virtual Annual Meeting (ASCO)
20
Supported by an independent educational grant from Merck Sharp & Dohme Corp.

Launch Date: July 16, 2021
Release Date: July 9, 2021
Expiration Date: June 30, 2022

June 30, 2022
Mini Module
7134
ClinicalClips_WebBanner.Melanoma(1150).gif
Hematology-Oncology